News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,242 Results
Type
Article (39806)
Company Profile (254)
Press Release (660182)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (204383)
Career Advice (2012)
Deals (35447)
Drug Delivery (96)
Drug Development (81138)
Employer Resources (172)
FDA (16195)
Job Trends (14879)
News (345535)
Policy (32563)
Tag
Academia (2555)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (49515)
ALS (94)
Alzheimer's disease (1380)
Antibody-drug conjugate (ADC) (134)
Approvals (16192)
Artificial intelligence (259)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11645)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (182)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (288)
Cancer (2308)
Cardiovascular disease (179)
Career advice (1679)
Career pathing (30)
CAR-T (154)
Cell therapy (433)
Cervical cancer (20)
Clinical research (66125)
Collaboration (851)
Company closure (2)
Compensation (555)
Complete response letters (19)
COVID-19 (2596)
CRISPR (41)
C-suite (249)
Cystic fibrosis (101)
Data (2289)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6380)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (101)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (86914)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112727)
Executive appointments (736)
FDA (17535)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (768)
Gene editing (109)
Generative AI (19)
Gene therapy (311)
GLP-1 (716)
Government (4425)
Grass and pollen (4)
Guidances (130)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (120)
Indications (29)
Infectious disease (2740)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (313)
IPO (16532)
IRA (40)
Job creations (3642)
Job search strategy (1424)
Kidney cancer (10)
Labor market (42)
Layoffs (475)
Leadership (17)
Legal (7912)
Liver cancer (76)
Lung cancer (324)
Lymphoma (157)
Machine learning (8)
Management (58)
Manufacturing (321)
MASH (71)
Medical device (13383)
Medtech (13388)
Mergers & acquisitions (19480)
Metabolic disorders (700)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1928)
NextGen: Class of 2025 (6523)
Non-profit (4481)
Now hiring (40)
Obesity (371)
Opinion (204)
Ovarian cancer (79)
Pain (92)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57409)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20611)
Phase II (29129)
Phase III (21681)
Pipeline (1307)
Policy (146)
Postmarket research (2564)
Preclinical (8764)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (384)
Real estate (5920)
Recruiting (65)
Regulatory (22339)
Reports (47)
Research institute (2321)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (133)
Series B (88)
Service/supplier (11)
Sickle cell disease (52)
Special edition (15)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3586)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (47)
The Weekly (31)
Vaccines (697)
Venture capitalists (42)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (217)
Last 7 days (903)
Last 30 days (3012)
Last 365 days (32627)
2025 (11526)
2024 (35253)
2023 (40104)
2022 (51231)
2021 (55762)
2020 (54123)
2019 (46565)
2018 (35042)
2017 (32145)
2016 (31522)
2015 (37590)
2014 (31361)
2013 (26382)
2012 (28585)
2011 (29284)
2010 (27353)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37948)
Australia (6213)
California (6330)
Canada (2052)
China (532)
Colorado (272)
Connecticut (277)
Delaware (157)
Europe (81494)
Florida (938)
Georgia (211)
Idaho (57)
Illinois (545)
India (25)
Indiana (318)
Iowa (11)
Japan (170)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (917)
Massachusetts (4698)
Michigan (223)
Minnesota (400)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1772)
New Mexico (28)
New York (1783)
North Carolina (985)
North Dakota (8)
Northern California (2781)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1425)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2379)
Tennessee (104)
Texas (942)
United States (23761)
Utah (187)
Virginia (151)
Washington D.C. (64)
Washington State (560)
West Virginia (3)
Wisconsin (56)
700,242 Results for "iovance biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
April 23, 2025
·
8 min read
Press Releases
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
May 2, 2025
·
7 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
7 min read
Press Releases
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
February 10, 2025
·
8 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - March 21, 2025
March 24, 2025
·
7 min read
Press Releases
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
February 27, 2025
·
23 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - June 21, 2024
Iovance Biotherapeutics, Inc. announced that on June 20, 2024, the Company approved the grant of inducement stock options covering an aggregate of 187,650 shares of Iovance’s common stock to forty-three new, non-executive employees.
June 21, 2024
·
7 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 21, 2025
February 24, 2025
·
7 min read
Press Releases
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
February 18, 2025
·
7 min read
Biotech Bay
Iovance Biotherapeutics to Present at Upcoming Conferences and Events - May 24, 2024
Iovance Biotherapeutics, Inc., a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte therapies for patients with cancer, announced that senior leadership plans to present at the following conferences and events.
May 24, 2024
·
6 min read
1 of 70,025
Next
